标题
Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas
作者
关键词
-
出版物
PEDIATRIC BLOOD & CANCER
Volume 60, Issue 6, Pages 1001-1008
出版商
Wiley
发表日期
2012-12-19
DOI
10.1002/pbc.24435
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized comparison of every-two-week v. every-three-week chemotherapy in Ewing sarcoma family tumors (ESFT)
- (2017) R. B. Womer et al. JOURNAL OF CLINICAL ONCOLOGY
- Second-look operation with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma (RMS): A report from the Children's Oncology Group (COG).
- (2017) D. A. Rodeberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Shorter duration therapy that includes vincristine (V), dactinomycin (A), and lower doses of cyclophosphamide (C) with or without radiation therapy for patients with newly diagnosed low-risk embryonal rhabdomyosarcoma (ERMS): A report from the Children’s Oncology Group (COG).
- (2017) D. Walterhouse et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study
- (2012) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- 18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models
- (2012) Anuradha Soundararajan et al. PEDIATRIC BLOOD & CANCER
- Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
- (2012) Suman Malempati et al. PEDIATRIC BLOOD & CANCER
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- (2011) M. M. Gounder et al. CLINICAL CANCER RESEARCH
- Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma
- (2011) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis
- (2011) Vera Paulson et al. GENES CHROMOSOMES & CANCER
- Local Control With Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group D9602 Study
- (2011) John Breneman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
- (2011) R. Beverly Raney et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance and Tumor Biology of Regional Lymph Node Disease in Patients With Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2011) David A. Rodeberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Anaplastic Lymphoma Kinase Aberrations in Rhabdomyosarcoma: Clinical and Prognostic Implications
- (2011) J. Carlijn van Gaal et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
- (2011) Patrick Schöffski et al. LANCET ONCOLOGY
- Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database
- (2011) Andrea Ferrari et al. PEDIATRIC BLOOD & CANCER
- Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Children's Oncology Group
- (2011) David O. Walterhouse et al. PEDIATRIC BLOOD & CANCER
- Targeting insulin-like growth factor 1 receptor in sarcomas
- (2010) Katia Scotlandi et al. CURRENT OPINION IN ONCOLOGY
- Inhibiting the VEGF–VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor
- (2010) Min S Park et al. CURRENT OPINION IN ONCOLOGY
- Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groups
- (2010) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- Local Therapy for Rhabdomyosarcoma of the Hands and Feet: Is Amputation Necessary? A Report From the Children's Oncology Group
- (2010) Trang H. La et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Regional Nodal Involvement and Patterns of Spread Along In-Transit Pathways in Children With Rhabdomyosarcoma of the Extremity: A Report From the Children's Oncology Group
- (2010) Trang H. La et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Influence of Noncompliance With Radiation Therapy Protocol Guidelines and Operative Bed Recurrences for Children With Rhabdomyosarcoma and Microscopic Residual Disease: A Report From the Children's Oncology Group
- (2010) Lynn Million et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2010) Leo Mascarenhas et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group
- (2010) Elai Davicioni et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
- (2010) Piotr Rutkowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
- (2010) Daniel Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
- (2009) Elai Davicioni et al. AMERICAN JOURNAL OF PATHOLOGY
- [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults
- (2009) Douglas S. Hawkins et al. CANCER
- Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
- (2009) K. Nishijo et al. CANCER RESEARCH
- Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
- (2009) Stefan Sleijfer et al. EUROPEAN JOURNAL OF CANCER
- RAS signaling dysregulation in human embryonal Rhabdomyosarcoma
- (2009) Simone Martinelli et al. GENES CHROMOSOMES & CANCER
- Primary Tumor Necrosis Predicts Distant Control in Locally Advanced Soft-Tissue Sarcomas After Preoperative Concurrent Chemoradiotherapy
- (2009) Dhara M. MacDermed et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients
- (2009) Iyad Sultan et al. JOURNAL OF CLINICAL ONCOLOGY
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
- (2009) Carola A.S. Arndt et al. JOURNAL OF CLINICAL ONCOLOGY
- Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors
- (2008) Alexander J.F. Lazar et al. AMERICAN JOURNAL OF PATHOLOGY
- New developments in multitargeted therapy for patients with solid tumours
- (2008) C. Le Tourneau et al. CANCER TREATMENT REVIEWS
- Clinical Significance of CXC Chemokine Receptor-4 and c-Met in Childhood Rhabdomyosarcoma
- (2008) F. Diomedi-Camassei et al. CLINICAL CANCER RESEARCH
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups
- (2008) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study
- (2008) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the children's oncology group
- (2008) Andrea Hayes-Jordan et al. JOURNAL OF PEDIATRIC SURGERY
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas
- (2008) S. L. Spunt et al. ONCOLOGIST
- Cancer Incidence Among Children and Adolescents in the United States, 2001-2003
- (2008) J. Li et al. PEDIATRICS
- Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
- Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group
- (2006) Carola A.S. Arndt et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started